Adam Morgan, Director of Heron Therapeutics HRTX, has filed 4 purchases and 0 sales on the open market. The latest trade was on 01/30.

AM

AM

Adam Morgan

Director

Company

Heron Therapeutics HRTX

First filing

23/02/24

Trades

31 trades

Buys / sales

4 / 0

12-month net buying

No record

Last trade

01/30

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Heron TherapeuticsHRTX	Open-market buy	25/08/08	25/08/12	1,766,546 sh	$1.50	$2,649,819	+25.3%
Jasper TherapeuticsJSPR	Open-market buy	24/02/08	24/02/09	350,000 sh	$12.95	$4,532,500	+41.7%
Heron TherapeuticsHRTX	Open-market buy	23/07/21	23/07/25	2,486,744 sh	$1.37	$3,406,839.28	+55.3%
AS Alimera Sciences	Open-market buy	23/05/17	23/05/19	1,401,901 sh	$1.70	$2,383,231.7	+543.9%